




Studies on Signal Transduction Pathway of b-Bungarotoxin-induced Neurotoxicity in the 






    The aim of this study is to elucidate the mechanism of neurotoxic effect of 
β-bungarotoxin on the cultured cerebellar granule neurons. β-BuTX exerted a potent 
neurotoxic effect upon mature granule neurons. Quantitative analysis of neurotoxicity 
revealed the time- and concentration-dependency. It is noted that β-BuTX appeared to 
initially destroy the neurite and then caused the neuronal death mediated by both apoptosis 
and necrosis processes. Nomarski optics showed that these neurons displayed 
morphological features of necrotic cells, including cell swelling, destruction of membrane 
integrity and eventual dissolution of the cell. Staining with the fluorescent dye Hoechst 
33258 showed that β-BuTX-treated neuron body had a higher densed staining with smaller 
apoptotic bodies. Using microspectrofluorimetry and fura-2 to measure [Ca2+]i, we found 
that β-BuTX markedly increased [Ca2+]i. Furthermore, BAPTA-AM, EGTA, MK 801 and 
diltiazem not only inhibit the elevated [Ca2+]i but also attenuate the neurotoxicity of 
β-BuTX.  
    Moreover, these Ca2+ inhibitors prevent the β-BuTX-induced reactive nitrogenous 
species production and NO synthase inhibitor (NG-methyl-L-arginine) exhibits the 
neuroprotection. Therefore, we conclude for the first report that β-BuTX-induced 
cerebellar granule neuron death is mediated by, at least in part, excessive generation of 
nitric oxide triggered by [Ca2+]i overloading. The activation of NMDA receptor and 
L-type calcium channel apparently involved in increasing [Ca2+]i induced by this 
neurotoxin. We suggest that this potent neurotoxin is a useful tool for us to study the 
neurotoxic process and thus we will be able to find the neuroprotective agent by using this 
model system. 
 
Neuronal death signaling through activating NMDA receptor and L-type calcium channel 
induced by β-bungarotoxin 
 
    The aim of this study is to elucidate the mechanism of neurotoxic effect of 
β-bungarotoxin (β-BuTX, a snake presynaptic neurotoxin isolated from the venom of 
Bungarus multicintus) on the cultured cerebellar granule neurons. β-BuTX exerted a potent 
neurotoxic effect upon mature granule neurons in the time-dependency. The mature 
neurons with an abundant of neurite outgrew were obtained after 7-8 days culture in vitro 
(DIV). By means of microspectrofluorimetry and fura-2, we measured intracellular Ca2+ 
concentration ([Ca2+]i) and founded that [Ca2+]i was increased markedly. BAPTA-AM, 
EGTA, MK801 and diltiazem prevented not only [Ca2+]i elevation, but also the neurotoxic 
effect by β-BuTX. The signaling pathway of the elevated [Ca2+]i in β-BuTX-induced 
neurotoxicity was studied. The results obtained indicated that β-BuTX increased reactive 
oxygen species production, followed by mitochondrial membrane potential reduction and 
ATP depletion. All of these events in signaling pathway were blocked by MK801, 
diltiazem, EGTA and BAPTA-AM. These findings suggested that the neurotoxic effect of 
β-BuTX was mediated by, at least in part, cascade events including the direct or indirect 
activation of NMDA receptor and L-type calcium channel followed by Ca2+ influx, 
oxidative stress, mitochondrial dysfunction and ATP depletion. We, therefore, suggest that 
this polypeptide neurotoxin resulting from its high potency and irreversible properties is a 
useful tool to elucidate the mechanism of neurodegenerative diseases. 
 
Suramin prevents neurotoxicity induced by β-bungarotoxin in cultured cerebellar granule 
neurons 
 
    We demonstrated in this paper that a snake presynaptic neurotoxin, β-bungarotoxin 
(β-BuTX), isolated from the venom of Bungarus multicintus, is a potent neurotoxicant with 
EC50 of 3 ng/ml (equivalent to 144 pM) on the cultured matured cerebellar granule 
neurons (CGNs). The neuronal death of CGNs induced by β-BuTX is apparently due to 
both apoptosis and necrosis processes as revealed by neurite fragmentation, morphological 
changes and staining the apoptotic bodies with the fluorescent dye Hoechst 33258. Using 
microspectrofluorimetry and fura-2 to measure intracellular calcium [Ca2+]i, we found that 
β-BuTX markedly increased intracellular calcium [Ca2+]i correlated with its neurotoxicity 
in a concentration- and time-dependent manner. The elevated [Ca2+]i is proposed to 
contribute the neurotoxic effect of β-BuTX, since suramin inhibited both the increased 
[Ca2+]i and the neurotoxicity. The mitochondria may be the executive site of the elevated 
intracellular calcium. By means of the fluorescent probes, 2,7-dichlorodihydrofluorescein 
diacetate (DCFH-DA) and 3,3’-dihexyloxacarbocyanine iodide (DiOC6), respectively, we 
showed that β-BuTX increased free radical production accompanied by the decreased 
mitochondrial membrane potential and eventually depleted the cellar ATP content. Suramin 
also effectively suppressed these detrimental effects of β-BuTX. Based on these findings 
together with the inhibitory effects of MK801 and EGTA on β-BuTX-neurotoxicity, it is 
concluded that β-BuTX acts, at least in part, as an activator of both P2X and NMDA 
receptors on CGNs. Activation of these receptor-cation channels increases an influx of 
extracellular Ca2+. Ca2+ overload damages mitochondria, leading to mitochondrial 
membrane depolarization, an increase in ROS production, a depletion of ATP content and 
eventually neuronal death. Our findings suggest that suramin with its beneficial protective 
effects on β-BuTX-induced neurotoxicity may provide an effective protective approach 
against chemical neurotoxic insults.  
 
 
Activation of NMDA receptor partly involved in β-bungarotoxin-induced neurotoxicity in 
cultured primary neurons 
 
    In this study, we demonstrated that a snake presynaptic toxin, β-bungantoxin 
(β-BuTX), was capable of binding to NMDA receptors of the cultured primary neurons 
(cerebellar granule neurons, CGNs). We labeled β-BuTX with fluorescent FITC 
(FITC-β-BuTX) and showed that the binding of FITC-β-BuTX was inhibited by unlabeled 
β-BuTX and MK-801 (a NMDA receptor antagonist). Meanwhile, the binding of 
[3H]-MK801 was also reduced by unlabeled MK-801 and β-BuTX. In addition, β-BuTX 
produced a very potent neurotoxic effect on the mature CGNs with the EC50 of 3 ng/ml 
(equivalent to 144 pM), but was less effective in the immature CGNs. We explored the 
signaling pathway of neuronal death and found that it was apparently due to the excessive 
production of reactive oxygen species (ROS) induced by β-BuTX. MK-801 and 
antioxidants (vitamin C, N-acetylcysteine, melatonin, epigallocatechin gallate, superoxide 
dismutase and catalase) attenuated not only ROS production but also 
β-BuTX-neurotoxicity. The downstream signaling of ROS was identified as the activation 
of caspase-3. Caspase inhibitor (z-DEVD-fmk) and antioxidants depressed both caspase-3 
activation and neurotoxicity. Based on these findings and our previous reports, we 
conclude that the binding and activation of NMDA receptors by β-BuTX was crucial step 
to produce the potent neurotoxic effect. The binding of NMDA receptors resulted in 
excessive Ca2+ influx, followed by ROS production and activation of caspase-3. This 
snake toxin is considered not only to be a useful tool for exploring the death-signaling 
pathway of neurotoxicity, but also provides a model for searching neuroprotective agents.  
 
Long-term lithium treatment prevents neurotoxic effects of β-bungarotoxin in the primary 
cultured neurons 
 
    Lithium is the most commonly used drug for the treatment of manic-depressive illness. 
The precise mechanisms underlying its clinical efficacy remain unknown. In this paper, we 
found that long-term exposure to lithium chloride protected cultured cerebellar granule 
neurons (CGNs) against β-bungarotoxin (β-BuTX)-induced neurotoxicity. This 
neuroprotection exhibited at the therapeutically relevant concentration of 1.2 mM lithium. 
Pretreatments for 3-5 days (long-term) were required for protection to occur; but a 3 hr 
treatment (short-term) was ineffective. In contrast, a longer treatment for 6-7 days or a 
higher concentration of 3 mM lithium led not only to lost of neuroprotective effect but also 
to neurotoxic effect. These findings suggest that lithium protection is limited to its narrow 
window of concentration and apparently relevant to its narrow therapeutic index in clinical 
application. Measurement of intracellular calcium [Ca2+]i revealed that neurotoxic 
concentrations of β-BuTX markedly increased [Ca2+]i, which could be attenuated by 
long-term, but not short-term, lithium treatment. Thus, the protection induced by lithium in 
CGNs was attributed to its inhibition of calcium overload. In addition, the Ca2+ signaling 
pathway, including reactive oxygen species production and mitochondrial membrane 
potential reduction, along with the neurotoxic effect of β-BuTX was blocked by long-term, 
but not short-term, lithium treatment. All of these results indicate that a crucial step for 
lithium protection is modulation of [Ca2+]I homeostasis and lithium neurotoxicity possibly, 
at least in part, is due to calcium overload. In conclusion, our results suggest that lithium, 
in addition to its use in treatment of bipolar depressive illness, may have an expanded use 
in intervention for neurotoxicity. 
 
Differential calcium signaling of β-bungarotoxin and 8-(N, N-diethylamino) octyl-3, 4, 
5-trimethoxybenzoate (TMΒ−8) linking the neuronal death in Primary Neurons 
 
    Ca2+ is an important secondary messenger in regulating various cellular functions. 
However, excessive intracellular Ca2+ ([Ca2+]i) is detrimental to cellular survival. 
Whether [Ca2+]i derived from different Ca2+ compartments can lead to differential cell 
death is still not known. In this paper, we compared the elevation of [Ca2+]i profile in 
relevance to neuronal death induced by β-bungarotoxin (β-BuTX; a presynaptic neurotoxin, 
increasing [Ca2+]i via activating NMDA receptor and L-type Ca2+-channel) and TMB-8 
(an prototypic intracellular Ca2+ antagonist), respectively in cultured rat cerebellar granule 
neurons (CGNs). We found that β-BuTX (5 nM) increased [Ca2+]i level was comparable 
to that induced by TMB-8 (100 μM) with a potency ratio of 20,000. The relationship 
between [Ca2+]i elevation and neuronal death induced by β-BuTX and TMB-8, 
respectively were apparently paralleled in a linear regression line; but β-BuTX exhibited 
about two folds more efficient than TMB-8 at equivalent [Ca2+]i elevation state. Prior 
exposure of TMB-8 (100 μM) exhibited neuroprotective effect against β-BuTX (5 nM); in 
accordance with shifting [Ca2+]i profile toward that of TMB-8. The morphological 
changes also supported the neuroprotective effect of TMB-8 against β-BuTX. Pretreatment 
with various selective inhibitors for preventing neurotoxic effects of β-BuTX and TMB-8, 
we found that thapsigargin (an inhibitor of endoplasmic reticulum Ca2+-ATPase) 
prevented the neurotoxic effect of TMB-8 but had no effect on β-BuTX; whereas diltiazem 
(an inhibitor of L-type Ca2+ channel) only inhibited β-BuTX, but not TMB-8-induced 
neurotoxicity. These findings support our working hypothesis that differential Ca2+ 
signaling derived from different Ca2+-compartmentation leads to differential neurotoxicity. 
    The results presented here show that (1) overstimulation of NMDA receptor and/or 
activation of L-type calcium channel deregulated homeostasis of [Ca+2]i and induced 
neuronal death; (2) massive Ca+2 influx induced ROS production; (3) ROS disturbed 
mitochondrial function and induced collapse of ΔΨ,which made ATP depletion. 
β-BuTX-induced Ca+2 influx is sufficient to make mitochondrial dysfunction; and Ca+2 
chelators decrease the incidence of neuronal death. The complex relationship between 
elevation of [Ca+2]i and mitochondrial function is a basis to formulate a model of 
β-BuTX-induced neuronal death essence; this model proposes that neuronal survival relies 
on a balance between mitochondrial function and [Ca+2]i homeostasis. Massive Ca+2 
influx induces an imbalance in mitochondrial homeostasis, leading to mitochondrial 
dysfunction, which triggers neuronal death (Fig. 0-1). We turn now to explore the 
experimental foundation of the model. 
 
中文摘要 
    神經細胞在體內生長需靠 neurotrophic factors 及神經的傳入刺激才能良好生
存，在體外培養的神經細胞則需使用含有血清的高鉀(25mM K+)培養液，成熟神經細
胞乃由小腦取出離體後培育 7-8 天(DIV)而得，已具有密致的神經突生長(neurite 





    乙型雨傘節蛇毒毒素(β-BuTX) 為一種由雨傘節 Bungarus multicintus 之毒素分
離出之突觸前神經蛇毒，此毒素抑制運動神經末端(motor nerve terminals)釋放乙醯膽
鹼(acetylcholine)，但其毒性分子作用機轉尚未完全明瞭。由於運動神經末端太細微，
難以傳統方法尋求 β-BuTX 之分子作用機轉。β-BuTX 對中樞神經系統或小腦顆粒神
經細胞作用也尚未研究清楚。為尋求可能作用目標，我們發現 β-BuTX對成熟小腦顆





鈣離子活化一氧化氮生成對 β-BuTX 引發小腦顆粒神經細胞毒性扮演重要角色 
 





分解(dissolution)。以螢光染料 Hoechst 33258 染色，顯示 β-BuTX 處理過之神經細胞
體(neuron body)呈現較亮而密集之凋亡細胞體(apototic bodies)。使用顯微光譜螢光計
量法(microspectrofluorimetry)與 fura-2 測量細胞內鈣離子濃度，我們發現 β-BuTX 顯
著增加細胞內鈣離子濃度，而此鈣離子濃度增加與其時間依存性及劑量依存性之神經
毒性有關聯性。再者，BAPTA-AM (細胞內鈣離子敖合劑)、EGTA (細胞外鈣離子敖
合劑)、MK801 (NMDA 受體拮抗劑)及 diltiazem (L 型鈣離子通道阻斷劑)不只抑制細
胞內鈣離子濃度之增加，也減弱 β-BuTX 之毒性。進一步發現，鈣離子抑制劑避免









β-BuTX 活化 NMDA 受體及 L 型鈣離子通道引發神經細胞毒性 
 
    本篇探討 β-BuTX 引發神經毒性之增加細胞內鈣離子濃度的訊息途徑。結果顯
示，β-BuTX 增加之反應性含氧物質(reactive oxygen species)生成，再造成粒腺體膜電
位降低及 ATP 排空。BAPTA-AM、 EGTA、MK801 及 diltiazem 可抑制以上所有反
應，顯示 β-BuTX 引發小腦顆粒神經細胞之神經毒性的訊息傳遞途徑可能部分經由直





Suramin 阻止 β-BuTX 引發小腦顆粒神經細胞毒性 
 
    Suramin 為一種無色染料，過去被用來當抗錐蟲藥及癌症治療之臨床試驗用藥，
此藥有許多藥理作用，包括為非選擇性之 P2 膘呤受體阻斷劑(non-selective blocker of 
P2 purinoceptors)，也被認為可能為 NMDA 受體拮抗劑。因此本實驗欲探究是否已知
suramin 對 NMDA受體之拮抗作用， 可用來對抗 β-BuTX 引發之神經毒性，而具神
經保護作用。既然 suramin 抑制鈣離子濃度增加及神經毒性，鈣離子濃度增加可能導
致 β-BuTX 之神經毒性反應。粒腺體可能為增加之鈣離子濃度的作用位置。分別藉由
螢光染料 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA)及 3,3’-dihexyloxa 
carbocyanine iodide (DiOC6)，我們測得 β-BuTX 增加自由基生成，伴隨粒腺體膜電位
降低及最終 ATP 排空。Suramin 亦有效地抑制這些 β-BuTX 之有害反應。基於這些
發現及 MK801 與 EGTA 抑制 β-BuTX 之毒性，我們所得的結論是 β-BuTX 對小腦
顆粒神經細胞作用的訊息傳遞途徑可能部分為 P2X receptors 與 NMDA receptors 之
活化劑(activator)。活化此受體陽離子通道(receptor-cation channels)增加細胞外鈣離子
內流，鈣離子過載損害粒腺體，造成粒腺體膜去極化，增加反應性含氧物質生成，而
使 ATP 排空，最後導致神經死亡。我們的發現指出，suramin 對 β-BuTX 
之毒性有保護作用，可提供對抗化合物神經毒性侵害之有效保護性研究。 
 
β-BuTX 引發小腦顆粒神經細胞毒性與其活化 NMDA 受體之相關性 
 
    我們的研究結果顯示，β-BuTX 能結合至小腦顆粒神經細胞之 NMDA 受體。我
們以螢光 FITC 標記 β-BuTX (FITC-β-BuTX)，發現 FITC-β-BuTX 之結合可被未標記
之 β-BuTX 及MK801 (NMDA 受體拮抗劑)抑制。同時，未標記之MK801 及 β-BuTX 
也會抑制[3H]-MK801之結合。我們探討 β-BuTX 引發小腦顆粒神經細胞毒性之作用
機轉，發現由於 β-BuTX 產生過多之反應性含氧物質而致。MK801 及抗氧化物 
(vitamin C, N-acetylcysteine, melatonin, epigallocatechin gallate, superoxide dismutase 與
catalase) 減弱反應性含氧物質之生成及 β-BuTX 引發之神經毒性反應。反應性含氧物
質之下游訊息為 caspase-3 之活化，caspase 抑制劑(z-DEVD-fmk) 及抗氧化物抑制
caspase-3 之活化與神經毒性。基於這些發現，我們所得的結論是 β-BuTX 結合並活
化 NMDA 受體為強效神經毒性反應之第一步驟，而結合 NMDA 受體會造成反應性
含氧物質生成及 caspase-3 之活化，進而導致細胞凋亡。 
 
長期鋰離子前處理減弱 β-BuTX 引發之小腦顆粒神經細胞毒性 
 
    鋰鹽為最常用來治療躁鬱症(manic-depressive illness)之藥物，突顯其臨床功效之
正確機轉尚未明瞭。本研究，我們發現長期處理氯化鋰可對抗 β-BuTX 對小腦顆粒神
經細胞引發之神經毒性。與臨床上相關濃度之 1.2 mM 鋰鹽表現神經保護作用。此神
經保護作用需 3-5 天前處理(長期)氯化鋰，3 小時(短期)則無效。相較之下，較長時











β-BuTX 與 TMΒ−8 之不同鈣離子訊息對神經細胞毒性影響 
 
    是否不同鈣離子來源所造成之細胞內鈣離子濃度變化會致使不同之細胞死亡仍
舊未知。本研究中，我們比較 β-BuTX (經由活化 
NMDA受體(NMDA receptors) 及L 型鈣離子通道(L-type calcium channel)而增加細胞
內鈣離子濃度)與TMΒ−8 (一種典型的細胞內鈣離子拮抗劑)對小腦顆粒神經細胞增加
細胞內鈣離子濃度與引發神經毒性之關聯。我們發現 5 nM之 β-BuTX增加細胞內鈣
離子濃度與 100 μM 之 TMΒ−8 增加相當，但 β-BuTX 強度(potency)高出兩萬倍。
β-BuTX 及 TMΒ−8 個別對細胞內鈣離子濃度之增加與引發神經細胞死亡呈平行之線
性回歸關係，但對相同細胞內鈣離子濃度之增加狀態下，β-BuTX 比 TMΒ−8 效力多
兩倍。然而前處理 TMΒ−8 (100 μM)可對抗 β-BuTX (5nM)而有神經保護作用，同時將
細胞內鈣離子濃度之量變曲線轉移向 TMΒ−8 之曲線型式。型態上之改變也支持了
TMΒ−8 可對抗 β-BuTX 而有神經保護作用。前處理各種選擇性的抑制劑來觀察對
β-BuTX及 TMΒ−8之對抗神經毒性作用，發現 thapsigargin (一種內質網鈣離子幫浦抑




度興奮 NMDA 受體與活化 L 型鈣離子通道導致鈣離子恆定失調引發神經毒性；(2)
大量鈣離子內流引發反 
    應性含氧物質及一氧化氮之生成；(3)反應性含氧物質損害粒腺體功能，使粒腺
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